apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges (2020) Gaipl U, Multhoff G, Pockley AG, Rödel F Journal article Combination of gas plasma and radiotherapy has immunostimulatory potential and additive toxicity in murine melanoma cells in vitro (2020) Pasqual-Melo G, Sagwal SK, Freund E, Gandhirajan RK, Frey B, von Woedtke T, Gaipl U, Bekeschus S Journal article Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials (2020) Zhou JG, Huang L, Jin SH, Xu C, Frey B, Ma H, Gaipl U Journal article, Review article Immune biological rationales for the design of combined radio- and immunotherapies (2020) Hader M, Frey B, Fietkau R, Hecht M, Gaipl U Journal article, Review article Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy (2020) Frey B, Mika J, Jelonek K, Cruz-Garcia L, Roelants C, Testard I, Cherradi N, et al. Journal article Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? (2020) Roedel F, Arenas M, Ott O, Fournier C, Georgakilas AG, Tapio S, Trott KR, Gaipl U Journal article, Review article Erste erfolgversprechende Ergebnisse der Kombination aus Strahlentherapie und Pembrolizumab beim metastasierten nichtkleinzelligen Lungenkarzinom (2020) Hecht M, Gaipl U, Fietkau R Journal article Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay (2020) Donaubauer AJ, Becker I, Rühle PF, Fietkau R, Gaipl U, Frey B Book chapter / Article in edited volumes Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma (2019) Zhou JG, Liang B, Jin SH, Liao HL, Du GB, Cheng L, Ma H, Gaipl U Journal article Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial) (2019) Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Hautmann MG, et al. Conference contribution